Latest Breaking News On - Investigative new drug - Page 1 : vimarsana.com

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJenene thomasPriya kumthekarWalter klempNorthwestern university investigative new drugMoleculin biotech incNorthwestern universitySecurities exchangeExchange commissionAmy heimberger at northwestern universityDrug administrationNational institutes of healthInvestigator initiated phaseMoleculin biotechInvestigative new drugNational institutes

Form 424B1 MIRA PHARMACEUTICALS,

Form 424B1 MIRA PHARMACEUTICALS,
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaCzech republicJohns hopkins universityBlue skyGeorgetown universityDistrict of columbiaBay shoreUnited kingdomNew jerseyCornell universityNew yorkFlorida international universityMontgomery countyState of floridaJonnier williams

ProMIS Neuroscience heading to $26, says Leede Jones Gable

Leede Jones Gable analyst Douglas W. Loe reiterated a Speculative Buy rating on drug developer ProMIS Neurosciences in a Monday report.

Noord hollandLeede jones gableDouglasw loeAlzheimer association international conferenceAcumen pharmaceuticalsStock quoteAssociation international conferenceGail farfelInvestigative new drug

Ethics Committee OKs Clinical Trial of IHL-42X for Sleep Apnea

Incannex received ethics approval to begin a bioavailability/bioequivalence clinical trial on IHL-42X, a drug candidate to treat OSA.

South australiaMark bleackleyBellberry human research ethics committeeDrug administrationClinical researchIncannex healthcare ltdInvestigative new drug

Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatmentSINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an.

United statesHan depingCecilia zhangBenjamin seetMichelle chenJean paul thieryIsaac chowLily peng yuemeiCheong wei yangJoan zhangGuangdong collaboration councilMinistry of trade industrySun yat sen university cancer centerDeputy partyCooperation councilTranslational medicine centre for tumour prevention